Panel Discussion

Saturday, March 8, 2025

5:00 PM – 5:20 PM ET

Moderator(s)

Rachel Barish, NP

Program Director, Infiltrative Cardiomyopathy
MedStar Health

Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Ahmed Khan, MD, MS

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose
David Xu, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

NA

Nana Afari-Armah, MD

MedStar Health

Disclosure(s): No financial relationships to disclose
Patrick T. Bering, MD

Cardiologist, Medical Director of Hypertrophic Cardiomyopathy
MedStar Washington Hospital Center
GLENELG, Maryland, United States

Disclosure(s): Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Nisha Gilotra, MD

Associate Professor of Medicine
Johns Hopkins University School of Medicine

Disclosure(s): No financial relationships to disclose
Jan Griffin, MD

Associate Professor of Medicine
Medical University of South Carolina
Charleston, South Carolina, United States

Disclosure(s): Astra Zeneca: Consulting Fees (e.g., advisory boards) (Ongoing); bridgebio: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
SJ

Sandeep Jani, MD, MPH

Medical Director, Hypertrophic Cardiomyopathy Program Baltimore, Medical director Advanced Heart Failure, Baltimore
MedStar Health
Baltimore, Maryland, United States

Disclosure(s): Bristol Meyers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
AK

Ajay Kadakkal, MD

Attending Physician
MedStar Health

Disclosure(s): No financial relationships to disclose
Mrinalini Krishnan, MD

Regional Director, Pulmonary Hypertension
MedStar Health

Disclosure(s): Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)
Mat Maurer, MD

Professor
Columbia University

Disclosure(s): Alexion: Consultant (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consultant (Ongoing), Grant/Research Support (Ongoing); Astra Zeneca: Consultant (Ongoing); Attralus: Grant/Research Support (Ongoing); bridgebio: Consultant (Ongoing), Grant/Research Support (Ongoing); Ionis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer,: Grant/Research Support (Ongoing)
Mitchell Psotka, MD PhD

System Chief, Heart Failure and Transplant
Inova Schar Heart and Vascular
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
Anirudh Rao, MD

Palliative Medicine Physician
MedStar Health, District of Columbia, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Rachel Barish, NP: AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Ahmed Khan, MD, MS: No financial relationships to disclose

David Xu, MD: No financial relationships to disclose

Nana Afari-Armah, MD: No financial relationships to disclose

Patrick T. Bering, MD: Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Nisha Gilotra, MD: No financial relationships to disclose

Jan Griffin, MD: Astra Zeneca: Consulting Fees (e.g., advisory boards) (Ongoing); bridgebio: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Sandeep Jani, MD, MPH: Bristol Meyers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Ajay Kadakkal, MD: No financial relationships to disclose

Mrinalini Krishnan, MD: Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)

Mat Maurer, MD: Alexion: Consultant (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consultant (Ongoing), Grant/Research Support (Ongoing); Astra Zeneca: Consultant (Ongoing); Attralus: Grant/Research Support (Ongoing); bridgebio: Consultant (Ongoing), Grant/Research Support (Ongoing); Ionis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer,: Grant/Research Support (Ongoing)

Mitchell Psotka, MD PhD: No financial relationships to disclose

Anirudh Rao, MD: No financial relationships to disclose